Form D · Other Technology
PatientBond, Inc.
Elmhurst, IL · CIK 0001701060
Offering snapshot reported Feb 11, 2021 · SEC filing
- Reported sold
- $8.19M Offering amount: $8.8M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $3K Reported outside-investor minimum
- First sale
- Jan 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2021 | Initial | $8,187,494 | No comparison | 20 | SEC filing |
| Aug 26, 2019 | Initial | $2,260,000 | No comparison | 4 | SEC filing |
| Jul 11, 2018 | Initial | $670,000 | No comparison | 10 | SEC filing |
| Mar 22, 2017 | Amendment | $2,287,073 | $0vs Mar 15, 2017 | 13 | SEC filing |
| Mar 15, 2017 | Initial | $2,287,073 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389203
Source: Form D, filed Feb 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Casey Albertson | Director |
| Justin Dearborn | Director, Executive |
| Beth Dreyer | Executive |
| Nicholas Gialamas | Director |
| Anurag Juneja | Director, Executive |
| Mark Kroeger | Director, Executive |
| Jonathan Phillips | Director |
| Nasrin Thierer | Director |
| Judd Weis | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
126 N. York St., Suite 2
Elmhurst, IL, 60126
Elmhurst, IL, 60126